구강 편평세포암에서 E-cadherin 유전자의 과메틸화
The hypermethylation of E-cadherin gene in oral squamous cell carcinoma
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Loss of E-cadherin (E-cad) expression has been found in multiple cancers and is postulated to facilitate tumor cell dissociation and metastais. Promotor methylation may provides an alternative pathway for loss of gene function. This study evaluated the role of hypermethylation in the down-regulation of E-cad in oral squamous cell carcinoma (OSCC). We examined the E-cad expression by immunohistochemical staining and detected methylation status by methylation-specific polymerase chain reaction (MSP) in 20 OSCC tissues. Overally, 12 (60%) cases of hypermethylation of E-cad were detected and we found there were no correlation between methylation and age, histologic grade, lympn node metastasis, tumor size and clinical stage. However, Eleven (73.3%) of 15 samples which was negative for E-cad staining showed hypermethylation of E-cad promotor region. On the other hand, only one (20%) of 5 E-cad positive sample was observed with methylated status. The underexpression of E-cad was found to be related to promotor hypermethylation (p=0.035). In conclusion, we suggest that hypermethylation play a role in inactivation of E-cad gene and may be a appreciable biomarker for diagnosis and treatment of OSCC.
Abstract
Loss of E-cadherin (E-cad) expression has been found in multiple cancers and is postulated to facilitate tumor cell dissociation and metastais. Promotor methylation may provides an alternative pathway for loss of gene function. This study evaluated the role of hypermethylation in the down-regulation of E-cad in oral squamous cell carcinoma (OSCC). We examined the E-cad expression by immunohistochemical staining and detected methylation status by methylation-specific polymerase chain reaction (MSP) in 20 OSCC tissues. Overally, 12 (60%) cases of hypermethylation of E-cad were detected and we found there were no correlation between methylation and age, histologic grade, lympn node metastasis, tumor size and clinical stage. However, Eleven (73.3%) of 15 samples which was negative for E-cad staining showed hypermethylation of E-cad promotor region. On the other hand, only one (20%) of 5 E-cad positive sample was observed with methylated status. The underexpression of E-cad was found to be related to promotor hypermethylation (p=0.035). In conclusion, we suggest that hypermethylation play a role in inactivation of E-cad gene and may be a appreciable biomarker for diagnosis and treatment of OSCC.
참고문헌 (25)
- Smith BD, "Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma", Radiat Oncol Invest, 7, pp.125~144 (1999)
- Pignatelli M, "Adhesion molecule ; Novel molecular tools in tumor pathology", Hum Pathol, 25, pp.849~856 (1994)
- Shiozaki H, "Expression of immunoreactive E-cadherin adhesion molecules in human cancers", Am J Pathol, 139, pp.17~23 (1991)
- 신재명, "구강 편평세포암종에서 E-cadherin의 발현과 임상병리학적 지표와의 관계", 대한구강악안면외과학회지, 31(1), pp.1~6 (2005), 대한구강악안면외과학회
- Herman JG, "Hypermethylation associated inactivation indicates a tumor suppressor role for p15INK4B1", Cancer Res, 56, pp.722~727 (1996)
- Widschwender M, "DNA methylation and breast carcinogenesis", Oncogene, 21, pp.5462~5482 (2002)
- Esteller M, "A gene hypermethylation profile of human cancer", Cancer Res, 61, pp.3225~3229 (2001)
- 최철영, "구강 편평세포암종에서의 p16INK4A와 p15INK4B발현과 메틸화의 관계", 대한구강악안면병리학회지, 27(3), pp.3~186 (2003), 대한구강악안면병리학회
- Nakayama S, "The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinoma", Int J Cancer, 93, pp.667~673 (2001)
- Yeh KT, "The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma", Anticancer Res, 22, pp.3971~3976 (2002)
- Chang HW, "Loss of Ecadherin expression resulting from promotor hypermethylation in oral tongue carcinoma and tis prognostic significance", Cancer, 94, pp.386~392 (2002)
- Ribeiro-Filho LA, "CpG Hypermethylation of Promoter Region and Inactivation of E-cadherin Gene in Human Bladder Cancer", Molecular Carcinogenesis, 34, pp.187~198 (2002)
- Widschwender M, "The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer", Clin Cancer Res, 8, pp.17~21 (2002)
- Johnson PJ, "Plasma nucleic acids in diagnosis and management of malignant disease", Clin Chem, 48, pp.1186~1193 (2002)
- Maruyama R, "Aberrant promotor methylation profile of bladder cancer and its relationship to clinicopathologic features", Cancer Res, 61, pp.8659~8663 (2001)
- 표성운, "구강 편평세포암종에서 E-cadherin과 β-catenin의 발현과 임상병리학적 특징", 대한악안면성형재건외과학회지, 28(5), pp.396~403 (2006), 대한악안면성형재건외과학회
- Sato T, "Allelotype of breast cancer; cumulative allele losses promote tumor progression in primary breast cancer", Cancer Res, 50, pp.7184~7189 (1990)
- Carter BS, "Allelic loss of chromosomes 16q and 10q in human prostate cancer", Proc Natl Acad Sci USA, 87, pp.8751~8755 (1990)
- Stone S, "Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer", Br J Cancer, 7, pp.1935~1937 (1999)
- Saito H, "Reduced expression of E-cadherin in oral squamous cell carcinoma; relationship with DNA methylation of 5’CpG island", Int J Oncol, 12, pp.293~298 (1998)
- Grunau C, "Bisulfite genomic sequencing; systemic investigation of critical experimental parameters", Nucl Acids Res, 29, pp.E65~E65 (2001)
- Bornman DM, "Methylation of the E-cadherin gene in bladder neoplasia and in normal uroepitheliaum from elderly individuals", Am J Pathol, 34, pp.187~198 (2001)
- Graff JR, "Methylation patterns of the E-cadherin 5’CpG islands are unstable and reflect dynamic, heterogenous loss of E-cadherin expression during metastatic progression", J Biol Chem, 275, pp.2727~2732 (2000)
- Nass SJ, "Aberrant methylation of the estrogen receptor and E-cadherin 5’CpG islands increases with malignant progression in human breast cancer", Cancer Res, 60, pp.4346~4348 (2000)
- Tamura G, "E-cadherin gene promoter hypermethlation in primary human gastric carcinomas", J Natl Cancer Inst, 92, pp.569~573 (2000)